Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Add-on to Insulin in Non-obese Autoimmune Diabetes
NCT03513874Phase 4Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Aug 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 1 diabetes mellitus (T1D), sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03513874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03513874.